Mirae Asset Global Etfs Holdings Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 72,113 shares of RARE stock, worth $3.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
72,113
Previous 92,824
22.31%
Holding current value
$3.12 Million
Previous $3.82 Million
4.98%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$430 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$242 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$221 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$180 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$133 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.03B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...